
- 100 free trades signup offer
- Easy-to-use platform
- Low fees
- Student and young investor discounts
Insulet Corporation is a medical devices business based in the US. Insulet Corporation shares (PODD) are listed on the NASDAQ and all prices are listed in US Dollars.
Its last market close was $255.44 – an increase of 1.44% over the previous week. Insulet Corporation employs 3,900 staff and has a trailing 12-month revenue of around $2.1 billion.Note: The dollar amounts in the table below are in Canadian dollars.
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.
Latest market close | $255.44 |
---|---|
52-week range | $160.19 - $289.46 |
50-day moving average | $272.25 |
200-day moving average | $234.41 |
Wall St. target price | $314.06 |
PE ratio | 42.2573 |
Dividend yield | N/A |
Earnings per share (TTM) | $5.79 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $244.67 from 2025-03-13
1 week (2025-03-07) | -2.84% |
---|---|
1 month (2025-02-14) | -12.79% |
3 months (2024-12-16) | -7.85% |
6 months (2024-09-16) | 4.61% |
1 year (2024-03-15) | 47.52% |
---|---|
2 years (2023-03-16) | -21.67% |
3 years (2022-03-16) | 2.53% |
5 years (2020-03-16) | 78.23% |
Valuing Insulet Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Insulet Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Insulet Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 42x. In other words, Insulet Corporation shares trade at around 42x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.
Insulet Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 6.2827. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Insulet Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
Insulet Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $389.7 million.
The EBITDA is a measure of a Insulet Corporation's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $2.1 billion |
---|---|
Operating margin TTM | 16.03% |
Gross profit TTM | $1.4 billion |
Return on assets TTM | 6.8% |
Return on equity TTM | 43.03% |
Profit margin | 20.19% |
Book value | $17.26 |
Market Capitalization | $17.2 billion |
TTM: trailing 12 months
We're not expecting Insulet Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Insulet Corporation's stocks have ranged in value from as little as $160.19 up to $289.46. A popular way to gauge a stock's volatility is its "beta."
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Insulet Corporation's is 1.287. This would suggest that Insulet Corporation's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts..
Want to dive into investing but don’t have much to spend? Take a look at these types of stocks.
Read more…Meme stocks can produce large gains in short periods, but the stocks are volatile.
Read more…Your guide to how ETFs work and whether this type of investment is right for you.
Read more…Steps to buying Coinbase stock in Canada with 24-hour and historical pricing before you buy.
Find out how the Trump tariffs will impact the stock market and explore Canadian stocks that may be resilient amidst tariffs.
Enjoy perks like free trades and cash back when you open a stock trading account with these online broker promotions.
Here’s our methodology for scoring the features that matter, and picking the top stock trading platforms in Canada.
These are the best renewable energy stocks to buy now in Canada.
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
Whether you’re a new or experienced investor, these are the best stock trading platforms and apps in Canada.
Buying US stocks in Canada is easier than you think. Find out how to buy US stocks in 4 simple steps.
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.
Questrade is a leader among Canadian discount brokerages, but is it right for you? Compare fees, features and alternatives here.